TheraRadar
Data updated: Mar 29, 2026

BAL

DIMERCAPROL
Approved 1946-05-06
Jump to: Indications Approvals Trials Competitors Similar Safety Patents
1
Indication
--
Phase 3 Trials
79
Years on Market

Details

Status
Prescription
First Approved
1946-05-06
Routes
INJECTION
Dosage Forms
INJECTABLE

Companies

PROVEPHARM SAS
Active Ingredient: DIMERCAPROL

BAL Approval History

Loading approval history...

What BAL Treats

4 indications

BAL is approved for 4 conditions since its original approval in 1946. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Premenstrual Syndrome
  • Irregular Menstrual Cycle
  • Water Retention
  • Depression
Source: FDA Label
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

BAL FDA Label Details

Pro

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

FDA Approval: NDA005939 → Patents: FDA Orange Book → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.